Beta thalassemia Treatment Market is projected to grow from USD 517.13 million in 2025 to USD 1.11 billion by 2036, at a CAGR of 7.2%. Blood Transfusions will dominate with a 34.6% therapy share, while Hospital Pharmacies will dominate with a 48.2% distribution channel share.